Bicillin L-A (Penicillin G Benzathine) 1.2 recall — Class II (D-0373-2024) · pharmaranks
Class IITerminated
Bicillin L-A (Penicillin G Benzathine) 1.2 recall
FDA recall D-0373-2024 · initiated Feb 7, 2024
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
cGMP Deviations: Products were stored outside the drug label specifications.
Details
Product
Bicillin L-A (Penicillin G Benzathine) 1.2, MMU / 2 mL Injection Prefilled Syringe 2 mL, Rx only, Mfg: Pfizer Pharmaceuticals, NDC 60793-0701-10
Recalling company
Mckesson Medical-Surgical Inc. Corporate Office
Classification
Class II
Status
Terminated
Type
Voluntary: Firm initiated
Distribution
Product was distributed to three direct accounts in NM, AZ and UT.
Initiated
Feb 7, 2024
FDA report date
Mar 20, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.